Home Editor's Blog News Special Reports Directory Events Advertise Submit Your News About Us Guides News by Zone I News by Date I News by Category   Home News By Category Stents Free Newsletter Register for our Free Newsletters Zones Analysis, Inspection and Laboratory Assisted/Independent Living Clinical and Nursing Equipment Design and Manufacture of Medical Equipment Diagnostics Equipment, Monitoring and Test Education, Training and Professional Services Health Education and Patient Management Health Estates Management Healthcare Support and Information Services Hygiene and Infection Control IT and Communications in Healthcare Materials Medical Device Technology Research and Development Safety and Security View All Other Carouselweb publications   Stents Cook Medical receives 510(k) clearance for the Evolution Biliary Controlled-Release Uncovered Stent Stents : 06 June, 2013 The Food and Drug Administration grants 510(k) clearance for the Evolution Biliary Controlled-Release Uncovered Stent from Cook Medical.   [ View Detail ] World's first dual therapy stent improves delayed coronary artery healing associated with monotherapy DES Stents : 29 May, 2013 OrbusNeich is launching what the company claims is the world's first dual therapy stent - the COMBO Dual Therapy Stent - to address the challenges of delayed healing of the coronary artery associated with monotherapy drug eluting stents (DES), the current standard of care for the treatment of coronary artery disease (CAD).   [ View Detail ] Two trials show positive results for drug-eluting stent technologies treating coronary heart disease Stents : 27 May, 2013 Boston Scientific reports positive results from two trials evaluating new, innovative drug-eluting stent (DES) technologies, which are emerging treatment options for coronary heart disease.   [ View Detail ] Self-apposing stent reinforces strength of clinical results Stents : 24 May, 2013 New one-year data is presented from the APPOSITION III clinical trial at the international EuroPCR conference in Paris, France.   [ View Detail ] Abbott receives CE Mark for world's longest coronary drug eluting stent Stents : 22 May, 2013 Abbott receives the CE Mark in Europe for the XIENCE Xpedition 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long blockages in the vessels that supply blood to the heart due to coronary artery disease (CAD).   [ View Detail ] Trial shows Genous stent is associated with lower restenosis rate compared to bare metal stents Stents : 22 May, 2013 OrbusNeich is reporting that the company's Genous Stent is associated with a significantly lower rate of binary restenosis compared to bare metal stents (BMS) in low-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients at six months.   [ View Detail ] Stentys enrolls first heart attack patient in US stent clinical trial Stents : 21 May, 2013 Stentys enrolls the first patient in APPOSITION V, the pivotal FDA-approved IDE trial which will enable the company to apply for marketing approval of the Self-Apposing Stent in the USA.   [ View Detail ] St Jude Medical receives CE approval of 3-D vessel reconstruction technology to improve stent placement Stents : 20 May, 2013 St Jude Medical receives CE Mark approval of the company's ILUMIEN OPTIS PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD).   [ View Detail ] Sentrant Introducer Sheath receives the CE mark Stents : 08 April, 2013 Medtronic's Sentrant Introducer Sheath receives the CE mark and will soon be launched internationally.   [ View Detail ] InspireMD receives CE Mark approval for carotid embolic protection stent Stents : 18 March, 2013 InspireMD, the developer of the MGuard Embolic Protection Stent (EPS), receives CE mark approval for the company's self-expanding Nitinol carotid EPS.   [ View Detail ] Covidien completes patient enrollment in iliac stent clinical study series Stents : 21 February, 2013 Covidien completes patient enrollment in the company's iliac stent clinical study series which is composed of two prospective, multinational, multicentre studies - VISIBILITY Iliac and DURABILITY Iliac.   [ View Detail ] Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary stent receives CE Mark approval Stents : 14 February, 2013 Boston Scientific receives CE Mark approval for the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent (DES) technology, and is starting its European market launch.   [ View Detail ] First patient starts treatment in the DIRECT II drug-eluting stent study Stents : 01 February, 2013 The first patient begins treatment in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) study at Middelheim Hospital in Antwerp, Belgium.   [ View Detail ] Covidien receives CE Mark approval for one-handed self-expanding peripheral stent Stents : 28 January, 2013 Covidien receives CE Mark approval for the company's EverFlex Self-expanding Peripheral Stent with Entrust Delivery System.   [ View Detail ] New drug eluting stent system offers delivery benefits Stents : 04 January, 2013 Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives US Food and Drug Administration (FDA) approval and is launching immediately in the USA, providing physicians with a next-generation technology that claims to offer the largest size matrix in the US market.   [ View Detail ] FSS introduces reconstrainable stent delivery technology in Europe Stents : 24 December, 2012 Flexible Stenting Solutions receives the CE Mark and is to market the company's 6 Fr Reconstrainable FlexStent Self-Expanding Stent System in the European Union.   [ View Detail ] First patient starts treatment in the ACES effectiveness study Stents : 21 December, 2012 Svelte Medical Systems is reporting the treatment of the first patient in the ACES (Acrobat Coronary stent system effectiveness European Study) clinical trial by Victor Legrand, MD, PhD at CHU Liege in Liege, Belgium.   [ View Detail ] First US patient is treated with first-of-its-kind drug-eluting peripheral stent Stents : 19 December, 2012 Riverside Methodist Hospital in Columbus, Ohio, USA, is treating the first patient with Cook Medical's Zilver PTX drug-eluting peripheral stent just weeks after the US Food and Drug Administration (FDA) approved the device.   [ View Detail ] First patient enrolls in multicentre study of the SYNERGY coronary stent system Stents : 03 December, 2012 The first patient enrolls in the Boston Scientific EVOLVE II clinical trial, which is designed to further assess the safety and effectiveness of the SYNERGY Stent System and support US Food and Drug Administration and Japanese regulatory approvals for the treatment of atherosclerotic coronary lesions.   [ View Detail ] Largest prospective study shows IVUS-guided stent placement improves patient outcomes Stents : 20 November, 2012 Volcano is reporting results from the largest study of its kind show that stent procedures guided by intravascular ultrasound (IVUS) resulted in better patient outcomes and fewer complications at 30 days and 12 months compared to procedures without IVUS, and were safe.   [ View Detail ] Zilver PTX stent achieves FDA approval as first drug-eluting stent in US to treat peripheral arterial disease Stents : 20 November, 2012 Cook Medical receives US Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver PTX Drug-Eluting Peripheral Stent portfolio, company officials reported today. It’s the first time the FDA has approved a drug-eluting stent to treat blockages in a peripheral artery.   [ View Detail ] SRS Medical acquires The Spanner Prostatic Stent from AbbeyMoor Medical Stents : 05 November, 2012 SRS Medical acquires The Spanner Temporary Prostatic Stent from AbbeyMoor Medical of Parkers Prairie, Minnesota, USA.   [ View Detail ] MAQUET joins Stent For Life Initiative Stents : 30 October, 2012 MAQUET is joining the Stent for Life initiative as an industry partner to support a coalition of leading organizations, including the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Society of Cardiology's Working Group on Acute Cardiac Care, and EuroPCR.   [ View Detail ] PROMUS Element platinum chromium stent demonstrates positive outcomes in patients with long coronary lesions Stents : 26 October, 2012 Boston Scientific is reporting clinical endpoint data from the PLATINUM Long Lesion trial, demonstrating positive outcomes for the PROMUS Element Everolimus-Eluting Platinum Chromium (PtCr) Stent System in patients with long coronary lesions.   [ View Detail ] STENTYS receives FDA approval to begin first US clinical trial with self-apposing stent Stents : 24 October, 2012 STENTYS receives Investigational Device Exemption (IDE) approval from the Food and Drug Administration (FDA) to conduct a pivotal clinical trial in the USA which, if successfully completed, will enable the company to apply for marketing approval of the STENTYS Self-Apposing stent which the company claims is the world's first and only Self-Apposing stent to treat acute myocardial infarction (AMI).   [ View Detail ] Svelte receives FDA approval to begin a study of coronary Stent Integrated Delivery System Stents : 23 October, 2012 Svelte Medical Systems receives conditional approval from the FDA to begin a pivotal study for the Svelte coronary stent Integrated Delivery System (IDS).   [ View Detail ] Zilver PTX stent trial shows sustained patency after three years Stents : 15 October, 2012 Cook Medical reports that three-year data from the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease demonstrates 70.7 percent primary patency in the superficial femoral artery (SFA) at 36 months for patients treated with the paclitaxel-eluting stent.   [ View Detail ] Cook Medical launches Zilver Vena venous self-expanding stent in Canada Stents : 09 October, 2012 Following Health Canada approval, Cook Medical is making the Zilver Vena Venous Self-Expanding Stent available to physicians across Canada at the 2012 Annual Meeting of the Canadian Society for Vascular Surgery.   [ View Detail ] New stent-delivery system facilitates implantation in more complex vessel anatomies Stents : 28 September, 2012 STENTYS is releasing Europe an enhanced stent-delivery system for the company's self-apposing stent.   [ View Detail ] Boston Scientific launches drug eluting stent to treat severe lesions below the knee Stents : 27 September, 2012 Boston Scientific is launching in European countries the PROMUS ELEMENT PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of certain severe peripheral artery lesions.   [ View Detail ] XIENCE Xpedition Everolimus eluting stent receives CE Mark Stents : 21 August, 2012 Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives CE Mark in Europe for the treatment of coronary artery disease.   [ View Detail ] Trial data shows stent delivers higher freedom from Target Lesion Revascularization rates Stents : 14 August, 2012 Three-year data from the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease indicates that Cook Medical's paclitaxel-eluting peripheral vascular stent demonstrated 83.0 percent freedom from TLR at 36 months in the PTX group, compared to 70.2 percent for patients treated with optimal percutaneous transluminal angioplasty and bare metal stents in the 479 patient study.   [ View Detail ] AXIOS stent and delivery system for biliary tract drainage receives CE Mark approval Stents : 19 July, 2012 Xlumena receives CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage.   [ View Detail ] Cook Medical receives 510(k) for Evolution colonic controlled-release stent Stents : 10 July, 2012 The US Food and Drug Administration (FDA) grants Cook Medical 510(k) clearance for Cook Medical's Evolution Colonic Controlled-Release Stent.   [ View Detail ] Stent shows strong performance in CAD patients with and without diabetes Stents : 29 May, 2012 The Resolute drug-eluting stent (DES) from Medtronic is shown in a new study to yields strong performance in coronary artery disease (CAD) patients both with and without diabetes through two years of follow-up.   [ View Detail ] Cook Medical launches first drug-eluting stent in Australia to treat PAD Stents : 22 May, 2012 Cook Medical is launching a first-of-its-kind drug-eluting peripheral stent in Australia, the Zilver PTX Drug-Eluting Peripheral Stent.   [ View Detail ] Boston Scientific receives FDA approval of EPIC vascular stent Stents : 21 May, 2012 Boston Scientific receives US Food and Drug Administration approval and is launching the Epic Vascular Self-Expanding Stent system.   [ View Detail ] Medtronic nets new indications for Resolute Integrity DES in Europe Stents : 18 May, 2012 Medtronic's Resolute Integrity Coronary Stent System receives European regulatory approval for several new indications, making it the drug-eluting stent (DES) with the broadest range of approved indications in Europe.   [ View Detail ] Boston Scientific launches Innova self-expanding bare-metal stent in Europe Stents : 17 May, 2012 Boston Scientific receives the CE Mark for the company's the Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery (SFA) and proximal popliteal artery (PPA).   [ View Detail ] Abbott receives approval for XIENCE PRIME stent in Japan Stents : 10 April, 2012 Abbott receives approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.   [ View Detail ] Clinical trials spotlight QCA outcomes Stents : 27 March, 2012 Boston Scientific reveals results from a quantitative coronary angiographic (QCA) analysis of the incidence of longitudinal stent deformation in the PERSEUS and PLATINUM randomized clinical trials, comprising more than 2,400 patients across three distinct coronary stent platforms: the Platinum Chromium Element platform (ION Paclitaxel-Eluting Stent System (TAXUS Element) and PROMUS Element Everolimus-Eluting Stent System), the Xience V/PROMUS Everolimus-Eluting Stent System, and the TAXUS Express Paclitaxel-Eluting Stent System.   [ View Detail ] Boston Scientific launches the WallFlex Biliary Transhepatic stent Stents : 23 March, 2012 Boston Scientific is launching the company's WallFlex Biliary Transhepatic Stent System both internaitonally and in the USA.   [ View Detail ] Coronary stent system receives regulatory approval in India Stents : 06 March, 2012 Cappella Medical Devices receives regulatory approval in India for the company's flagship Sideguard Coronary Stent system which claims to offer superior outcomes in treating patients percutaneously for complex and bifurcated lesions.   [ View Detail ] Boston Scientific launches of PROMUS Element stent in Japan Stents : 02 March, 2012 Boston Scientific is launching the PROMUS Element Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan.   [ View Detail ] Resolute Integrity DES gains FDA approval for treating CAD Stents : 21 February, 2012 Medtronic receives US Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease (CAD).   [ View Detail ] Boston Scientific Epic stent shows positive clinical outcomes Stents : 17 January, 2012 Boston Scientific is reporting nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.   [ View Detail ] OrbusNeich's Genous stent achieves good, comparable clinical outcomes Stents : 09 January, 2012 OrbusNeich is reporting 12-month follow-up data from a post-hoc analysis of the e-HEALING registry demonstrate that the company's Genous Stent achieves good, comparable clinical and safety outcomes in patients discontinuing dual antiplatelet therapy (DAPT) at 30 days and at six months.   [ View Detail ] Boston Scientific is reports results from the EVOLVE first human use trial Stents : 15 November, 2011 Boston Scientific is reporting results from the EVOLVE First Human Use trial demonstrating the non-inferiority of the SYNERGY Everolimus-Eluting Stent System compared to the PROMUS Element Everolimus-Eluting Stent System in treating de novo coronary artery lesions.   [ View Detail ] Carotid Wallstent found safe for high surgical risk patients Stents : 10 November, 2011 Boston Scientific is reporting positive outcomes from the CABANA post-approval study of the Carotid WALLSTENT Monorail Endoprosthesis used in conjunction with its FilterWire EZ Embolic Protection System in routine clinical practice.   [ View Detail ] Svelte Medical systems treats first patient in DIRECT stent study Stents : 10 November, 2011 Svelte Medical Systems is reporting the treatment of the first patient in the DIRECT (Direct-on-a-wire Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study at Auckland City Hospital in Auckland, New Zealand.   [ View Detail ] First | Prev  | 1 | 2 | 3 | 4 | 5  | Next  | Last

Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides      © 2012 ProHealthServiceZone.com